For instance, Zheng et al. reported that FLT3 and TP53 mutations are common in Chinese ALL patients (31), and Zhang et al. reported high rates of FLT3 mutations in B-ALL (32). Here, FLT3 is linked to acute lymphoblastic leukemia.